Historical record - last NADAC effective date: 10/18/2017
Product Information
TOPIRAMATE ER 50 MG CAPSULE is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $6.1393 per EA under NDC 00832107215. Its NADAC has been published 113 times since Jul 22, 2015.
FDA first approved this application on Mar 11, 2014. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Upsher-Smith Laboratories LLCNDC
00832107215
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
10/18/2017
Active Ingredients
TOPIRAMATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA205122FDA Approved
3/11/2014
TE Code
AB2
On Market Since
7/7/2014
Pharmacological Classes
Price Statistics
The NADAC for TOPIRAMATE ER 50 MG CAPSULE has been published 113 times since Jul 22, 2015, and over the history we have for it it has risen 23.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.1393 per EA |
|---|---|
| All-time high | $6.1393 (Nov 8, 2017) |
| All-time low | $4.9595 (Jul 22, 2015) |
| Median price | $5.1856 |
| Average price | $5.1088 |
| Largest weekly change | +18.4% (Oct 18, 2017) |
| Weeks tracked | 113 |
| Tracking since | Jul 22, 2015 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+23.8%
Last surveyed Nov 8, 2017 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 45% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TOPIRAMATE ER 50 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE ER 50 MG CAPSULE, manufactured by Upsher-Smith Laboratories LLC, is $6.1393 per EA (NDC 00832107215), effective Nov 8, 2017.
How has the price of TOPIRAMATE ER 50 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TOPIRAMATE ER 50 MG CAPSULE has risen 23.8%. It has been tracked across 113 weekly CMS publications since Jul 22, 2015.
What are the highest and lowest recorded NADAC prices for TOPIRAMATE ER 50 MG CAPSULE?
Since Jul 22, 2015, the NADAC for TOPIRAMATE ER 50 MG CAPSULE has ranged from a low of $4.9595 (Jul 22, 2015) to a high of $6.1393 (Nov 8, 2017), with a median of $5.1856 per EA.
Are there cheaper alternatives to TOPIRAMATE ER 50 MG CAPSULE?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TOPIRAMATE ER 50 MG SPRINKL CAP, is $3.3778 per EA — about 45% below TOPIRAMATE ER 50 MG CAPSULE.
Who manufactures TOPIRAMATE ER 50 MG CAPSULE?
TOPIRAMATE ER 50 MG CAPSULE (NDC 00832107215) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.